Skip to main content
Log in

A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Repeated withdrawals from chronic forced ethanol exposure sensitize animals to withdrawal-induced deficits in social interaction behavior. The deficits in social interaction behavior following withdrawal from continuous ethanol exposure can be reduced following acute treatments with 5-HT2C antagonists or 5-HT1A agonists.

Objectives

The present study investigated whether prior treatment with these serotonergic agents during early withdrawals in rats subjected to repeated withdrawals from ethanol exposure would ameliorate the social interaction deficits observed following the final withdrawal.

Methods

Sprague-Dawley rats were exposed to three cycles of 5 days forced ethanol (7%, w/v), with 2 days of control diet after the first and second cycles. Drugs were administered IP 4 h after removal of ethanol on the first and second cycles but not the third in one group and 4.5 h after removal of ethanol on the third cycle in another. The social interaction test was performed 5 h after removal of ethanol on the third cycle. Drugs tested included SB-242084, a 5-HT2C antagonist; buspirone, a 5-HT1A partial agonist; WAY-100635, a 5-HT1A antagonist; ketanserin, a 5-HT2A antagonist; ritanserin, a mixed 5-HT2A/2C antagonist; and Ro-601075, a 5-HT2C agonist.

Results

Both SB-242084 and buspirone reduced ethanol withdrawal-induced deficits in social interaction when given either acutely 30 min before the test or at 4 h after withdrawal from the first and second cycles. WAY-100635 and ketanserin were completely ineffective regardless of mode of treatment. In contrast, the 5-HT2C agonist, Ro-601075, accentuated the withdrawal-induced deficit in social interaction behavior in rats exposed to either 4.5 or 7% ethanol diet.

Conclusions

These results support the utility of 5-HT1A agonists and 5-HT2C antagonists in reducing anxiety-like behavior induced by ethanol withdrawal and reducing the adaptive changes associated with repeated withdrawals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

References

  • Amano M, Goto A, Sakai A, Achita M, Takahashi N, Hara C, Ogawa N (1993) Comparison of the anticonflict effect of buspirone and its major metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in rats. Jpn J Pharmacol 61:311–317

    CAS  PubMed  Google Scholar 

  • Andrews N, File SE (1993) Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supported neurochemical and behavioural evidence. Psychopharmacology 112: 21–25

    Google Scholar 

  • Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S (2001) Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4:399–408

    CAS  PubMed  Google Scholar 

  • Ballenger JC, Post RM (1978) Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry 133:1–14

    CAS  PubMed  Google Scholar 

  • Berggren U, Eriksson M, Fahlke C, Balldin J (2002) Is long-term heavy alcohol consumption toxic for brain serotonergic neurons? Relationship between years of excessive alcohol consumption and serotonergic neurotransmission. Drug Alcohol Depend 65:159–165

    Article  CAS  PubMed  Google Scholar 

  • Boess FG, Martin H (1994) Molecular biology of 5-HT receptors Neuropharmacology 33:275–317

    Article  CAS  Google Scholar 

  • Bonhaus DW, Weinhardt KK, Taylor M, De Souza A, McNeeley PM, Szezcpanski K, Fontana DJ, Trinh J, Rocha CL, Dawson MW, Flippin LA, Eglin RM (1997) RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 36:621–629

    Google Scholar 

  • Bristow LJ, O'Connor D, Watts R, Duxon MS, Hutson PH (2000) Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY-100635, in the rat. Neuropharmacology 39:123–132

    Article  PubMed  Google Scholar 

  • Bruno F (1989) Buspirone in the treatment of alcoholic patients. Psychopathology 22:49–59

    PubMed  Google Scholar 

  • Cao BJ, Rodgers RJ (1997) Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze. Neuropharmacology 36:1089–1097

    Article  CAS  PubMed  Google Scholar 

  • Curran GM Flynn HA, Kirchner J, Booth BM (2000) Depression after alcohol treatment as a risks factor for relapse among male veterans. J Subst Abuse Treat 19:259–265

    Article  CAS  PubMed  Google Scholar 

  • De Soto CB, O'Donnell WE, De Soto JL (1989) Long-term recovery in alcoholics. Alcohol Clin Exp Res 13:693–697

    PubMed  Google Scholar 

  • Dougherty RJ, Gates RR (1990) The role of buspirone in the management of alcohol withdrawal: a preliminary investigation. J Subst Abuse Treat 7:189–192

    Article  CAS  PubMed  Google Scholar 

  • Driessen M, Meier S. Hill A (2001) The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol 36:249–255

    Article  CAS  PubMed  Google Scholar 

  • Fawcett J, Kravitz HM, McGuire M, Easton M, Ross J, Pisani V, Fogg LF, Clark D, Whitney M, Kravitz G, Javaid J, Teas G (1999) Pharmacological treatments for alcoholism: revisiting lithium and considering buspirone. Alcohol Clin Exp Res 24:666–674

    Google Scholar 

  • File SE (1980) The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Meth 2:219–238

    CAS  PubMed  Google Scholar 

  • File SE, Andrews N, al-Farhan M, Wu PY (1993) The role of 5-HT in the anxiogenic effects of acute ethanol withdrawal and in the long-lasting cognitive deficits. Alcohol Alcohol 28:495–499

    Google Scholar 

  • Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A (1995) A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur J Pharmacol 281:81–88

    CAS  PubMed  Google Scholar 

  • Frye GD, McCown TJ, Breese GR (1983) Differential sensitivity of ethanol withdrawal signs in the rat to γ-aminobutyric acid (GABA) mimetics: blockade of audiogenic seizures but not forelimb tremors. J Pharmacol Exp Ther 226:720–725

    Google Scholar 

  • George DT, Rawlings R, Eckhardt MJ, Phillips MJ, Shoaf SE, Linnoila M (1999) Buspirone treatment of alcoholism: age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking. Alcohol Clin Exp Res 23:272–278

    CAS  PubMed  Google Scholar 

  • Gonzalez LE, File SE, Overstreet DH (1998) Selectively bred lines of rat differ in social interaction and hippocampal 5-HT1A receptor function: a link between anxiety and depression? Pharmacol Biochem Behav 59:787–792

    Article  CAS  PubMed  Google Scholar 

  • Hedlund L, Wahlstrom G (1999) Acute and long-term effects of buspirone treatment on voluntary ethanol intake in a rat model of alcoholism. Alcohol Clin Exp Res 23:822–827

    CAS  PubMed  Google Scholar 

  • Kampov-Polevoy AB, Matthews DB, Gause L, Morrow AL, Overstreet DH (2000) P rats develop physical dependence on alcohol via voluntary drinking: changes in seizure thresholds, anxiety, and patterns of alcohol drinking. Alcohol Clin Exp Res 24:278–284

    Google Scholar 

  • Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP (1997) SB-242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36:609–620

    CAS  PubMed  Google Scholar 

  • Kennett G, Lightowler S, Trail B, Bright F, Bromidge S (2000) Effects of Ro-600175, a 5-HT2C receptor agonist, in three animal models of anxiety. Eur J Pharmacol 387:197–204

    CAS  PubMed  Google Scholar 

  • Knapp DJ, Duncan GE, Crews FT, Breese GR (1998) Induction of Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further evidence for withdrawal-induced anxiety. Alcohol Clin Exp Res 22:481–493

    CAS  PubMed  Google Scholar 

  • Knapp DJ, Overstreet DH, Breese GR (2000) Pharmacological modulation of anxiety in rats during alcohol withdrawal. Presented at 23rd Annual Meeting of the Research Society on Alcoholism, Denver, CO, June 24–29, 2000. Alcohol Clin Exp Res 24:90A

    Google Scholar 

  • Knapp DJ, Overstreet DH, Breese GR (2001) Persistent effects of repeated ethanol withdrawal are blunted by pharmacological treatments during early withdrawal episodes. Presented at 24th Annual Meeting of Research Society on Alcoholism, Montreal, Canada, June 23–28, 2001. Alcohol Clin Exp Res 25:23A

    Google Scholar 

  • Kranzler H, Meyer RF (1992) An open trial of buspirone in alcoholics. J Clin Psychopharmacol 9:379–380

    Google Scholar 

  • Lal H, Prather PL, Rezazadeh SM (1991) Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: reversal by buspirone. Alcohol 8:467–471

    CAS  PubMed  Google Scholar 

  • Lal H, Prather PL, Rezazadeh SM (1993) Potential role of 5-HT1C and 5-HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal. Alcohol Clin Exp Res 17:411–417

    CAS  PubMed  Google Scholar 

  • Malcolm R, Anton RF, Randall CL, Johnston A, Brady K, Thevos A (1992) A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res 16:1007–1013

    Google Scholar 

  • Malec TS, Malec EA, Dongier M (1996) Efficacy of buspirone in alcohol dependence: a review. Alcohol Clin Exp Res 20:853–858

    CAS  PubMed  Google Scholar 

  • McCown TJ, Breese GR (1990) Multiple withdrawals from ethanol "kindles" inferior collicular seizure activity: evidence for kindling of seizures associated with alcoholism. Alcohol Clin Exp Res 14:394–399

    CAS  Google Scholar 

  • Meert TF (1994) Ritanserin and alcohol abuse and dependence. Alcohol Alcohol 2:523–530

    CAS  Google Scholar 

  • Miller WR, Harris RJ (2000) A simple scale of Gorski's warning signs for relapse. J Stud Alcohol 61:759–765

    CAS  PubMed  Google Scholar 

  • Moy SS, Knapp DJ, Criswell HE, Breese GR (1997) Flumazenil blockade of anxiety following ethanol withdrawal in rats. Psychopharmacology 131:354–360

    Google Scholar 

  • Moy SS, Knapp DJ, Duncan GE, Breese GR (2000) Enhanced ultrasonic vocalization and Fos protein expression following ethanol withdrawal: effects of flumazenil. Psychopharmacology 152:208–215

    Article  CAS  PubMed  Google Scholar 

  • Naranjo CA, Poulos CX, Lanctot KL, Bremner KER, Kowk M, Umana M (1995) Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects. Addiction 90:893–905

    Article  CAS  PubMed  Google Scholar 

  • Overstreet DH, Rezvani AH, Pucilowski O, Janowsky DS (1994) 5-HT receptors: implications for the neuropharmacology of alcohol and alcoholism. Alcohol Alcohol Suppl 2:207–212

    Google Scholar 

  • Overstreet DH, Knapp DJ, Breese GR (2002) Accentuated decrease in social interaction in rats repeatedly withdrawn from ethanol. Alcohol Clin Exp Res 26:1259–1268

    PubMed  Google Scholar 

  • Pandey SC, Pandey GN (1996) Modulation of serotonin2A/2C receptors and these receptor-linked phosphoinositide system by ethanol. Behav Brain Res 73:235–238

    Article  CAS  PubMed  Google Scholar 

  • Pandey SC, Piano MR, Schwertz DW, Davis JM, Pandey GN (1992) Effect of ethanol administration and withdrawal on serotonin receptor subtypes and receptor-mediated phosphoinositide hydrolysis in rat brain. Alcohol Clin Exp Res 16:1110–1116

    Google Scholar 

  • Soloff PH, Lynch KG, Moss HB (2000) Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study. Alcohol Clin Exp Res 24:1609–1619

    CAS  PubMed  Google Scholar 

  • Stahl S (1997) Mixed depression and anxiety: serotonin1a receptors as a common pharmacologic link. J Clin Psychiatry 58:20–26

    CAS  Google Scholar 

  • Strowig AB (2000) Relapse determinants reported by men treated for alcohol addiction: the prominence of depressed mood. J Subst Abuse Treat 19:469–474

    Article  CAS  PubMed  Google Scholar 

  • Tollefson GD, Montagu-Clouse J, Tollefson SF (1992) Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). J Clin Psychopharmacol 12:19–25

    CAS  PubMed  Google Scholar 

  • Ulrichsen J (1991) Alterations in serotonin receptor subtypes in ethanol-dependent rats. Alcohol Alcohol 26:567–573

    CAS  PubMed  Google Scholar 

  • Wallis CJ, Rezazadeh SM, Lal H (1993) Role of serotonin in ethanol abuse. Drug Dev Res 30:178–188

    CAS  Google Scholar 

  • Wiesbeck GA,Weijers HG, Chick J, Naranjo A, Boening J (1999) Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multi-center trial. Ritanserin in Alcoholism Work Group. Alcohol Clin Exp Res 23:230–235

    CAS  PubMed  Google Scholar 

  • Wiesbeck GA, Weijers HD, Chick J, Boening J (2000) The effects of ritanserin on mood, sleep, vigilance, clinical impression, and social functioning in alcohol-dependent individuals. Ritanserin in Alcoholism Work Group. Alcohol Alcohol 35:384–389

    Article  CAS  PubMed  Google Scholar 

  • Yocca FD (1990) Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postynaptic 5-HT1A receptors. J Clin Psychopharmacol 10:6S–12S

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank Matthew Crist, Dhritiman Mukherjee, Rebecca Overstreet, Leo Orlov, and Qi Yu for technical assistance. We thank the Case Western University web site for information about the affinity of the various serotonergic drugs (www.pdsp.cwru.edu/pdsp/asp). This work was supported by NIAAA grants AA 00243, AA 11605, and AA 00214.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David H. Overstreet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Overstreet, D.H., Knapp, D.J., Moy, S.S. et al. A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats. Psychopharmacology 167, 344–352 (2003). https://doi.org/10.1007/s00213-003-1425-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1425-y

Keywords

Navigation